The Reta 40 Pen delivers premium, research-grade Reta 40mg in a convenient reusable injection pen format. This advanced triple-agonist peptide targets GLP-1, GIP, and glucagon receptors, and is supplied in a multi-dose device designed to support precise and repeatable administration within metabolic and weight-management research models.
The reusable pen format is designed for extended study protocols, allowing accurate dose dialling while minimising waste and improving consistency compared with traditional single-use vials or syringes.
This product is sold for research purposes only.